Skip to main content
7707 Results
 
msf-placeholder
HIV/AIDS

STI crisis in the West: Fuelling AIDS in Côte d’Ivoire

The civil war and subsequent collapse of the healthcare system have provoked a medical crisis in parts of Ivory Coast. Responding over the past two years to high levels of malaria, malnutrition and other diseases, MSF teams in the West of the country have encountered an alarmingly high number of sexually transmitted infections ("STIs"). Report - 27 Apr 2005
 
msf-placeholder
Humanitarian challenges

Courtcase of the Dutch Government against MSF

"To be crystal clear, MSF never borrowed any money from the Dutch government and in addition, the Dutch government negotiated, on its own, the terms and conditions for Arjan's release, only informing MSF at the last minute" - International Council President Rowan Gillies. Interview - 22 Apr 2005
 
msf-placeholder
India

The future of generic medicines made in India

Prognosis: Short-term relief, long-term pain. The long-term impact of the Indian Patent Act is bad news for those relying on affordable new medicines - in MSF's own HIV/AIDS projects, for instance, approximately 70% of all patients currently take generic ARV medicines made in India. Worldwide, an estimated 350,000 people on ARV treatment depend on Indian generic production - that's half of all those on ARVs in developing countries. Project Update - 21 Apr 2005
 
msf-placeholder
Angola

Stronger measures needed in Marburg Fever outbreak in Angola

Marburg Fever continues to spread in the Angolan province of Uige. To date, the official deathtoll stands at 235, with 257 reported cases. Biological tests carried out by the WHO confirmed on March 22 the presence of the virus. Since then, 114 new cases have been identified, 107 of which have proved fatal. Project Update - 20 Apr 2005
 
msf-placeholder
Tuberculosis

World TB Day 2005: Development of simple and rapid diagnostic tools key for fighting tuberculosis

MSF is committed to participating to the development of new tests by assessing the feasibility of new technology in our field projects. Press Release - 15 Apr 2005
 
msf-placeholder
Sudan

A Financial Controller's Story

Voices from the Field - 13 Apr 2005
 
msf-placeholder
Niger

Alarming increase in malnutrition in Niger

In our Maradi programme in south-east Niger, the number of children arriving with severe malnutrition continues to climb. In 2004, MSF treated nearly 10,000 cases and, since the beginning of this year, the situation has deteriorated: in the villages where MSF has recently visited, one out of every five children is at risk of malnutrition. Project Update - 12 Apr 2005
 
msf-placeholder
Sudan

MSF condemns violence in Darfur

Over the past year, MSF has systematically denounced the massive campaign of violence directed at civilians in Darfur led by pro-government 'Janjaweed' militia and Sudanese army units. Statement - 8 Apr 2005
 
msf-placeholder
Natural hazards

Asian tsunami: Three months financial overview

In an extraordinary demonstration of public support, MSF offices worldwide saw an unprecedented surge of spontaneous donations. Project Update - 8 Apr 2005
 
msf-placeholder
Global health

The beginning of the end of affordable generics

People who rely on low-cost medicines will have to wait three years before a generic company can even make an application for a right to produce the drug. Whereas people in wealthy countries will have access to new medicines immediately when they are proved safe and effective, people in poor countries will have to wait years. Press Release - 22 Mar 2005
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more